−0.11 USD
403.78 K USD
0.00 USD
2.00 M
About Bellevue Life Sciences Acquisition Corp.
Sector
Industry
CEO
Guk-Hyun Hwang
Headquarters
Bellevue
Founded
2020
FIGI
BBG01752PPQ2
Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of BLAC is 11.27 USD — it has increased by 0.09% in the past 24 hours. Watch Bellevue Life Sciences Acquisition Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Bellevue Life Sciences Acquisition Corp. stocks are traded under the ticker BLAC.
BLAC stock has fallen by −2.00% compared to the previous week, the month change is a −4.33% fall, over the last year Bellevue Life Sciences Acquisition Corp. has showed a 7.74% increase.
BLAC reached its all-time high on Nov 14, 2024 with the price of 13.40 USD, and its all-time low was 10.07 USD and was reached on Mar 20, 2023. View more price dynamics on BLAC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
BLAC stock is 2.04% volatile and has beta coefficient of −0.14. Track Bellevue Life Sciences Acquisition Corp. stock price on the chart and check out the list of the most volatile stocks — is Bellevue Life Sciences Acquisition Corp. there?
Today Bellevue Life Sciences Acquisition Corp. has the market capitalization of 46.07 M, it has increased by 0.66% over the last week.
Yes, you can track Bellevue Life Sciences Acquisition Corp. financials in yearly and quarterly reports right on TradingView.
BLAC net income for the last quarter is −230.96 K USD, while the quarter before that showed −97.30 K USD of net income which accounts for −137.38% change. Track more Bellevue Life Sciences Acquisition Corp. financial stats to get the full picture.
No, BLAC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 2.00 employees. See our rating of the largest employees — is Bellevue Life Sciences Acquisition Corp. on this list?
Like other stocks, BLAC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Bellevue Life Sciences Acquisition Corp. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Bellevue Life Sciences Acquisition Corp. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Bellevue Life Sciences Acquisition Corp. stock shows the buy signal. See more of Bellevue Life Sciences Acquisition Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.